Iovance Biotherapeutics (LTS:0JDK) Accounts Payable & Accrued Expense : $113.2 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Iovance Biotherapeutics Accounts Payable & Accrued Expense?

Iovance Biotherapeutics's quarterly accounts payable & accrued expense increased from Sep. 2024 ($106.5 Mil) to Dec. 2024 ($109.4 Mil) and increased from Dec. 2024 ($109.4 Mil) to Mar. 2025 ($113.2 Mil).

Iovance Biotherapeutics's annual accounts payable & accrued expense increased from Dec. 2022 ($78.9 Mil) to Dec. 2023 ($102.5 Mil) and increased from Dec. 2023 ($102.5 Mil) to Dec. 2024 ($109.4 Mil).

Iovance Biotherapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Iovance Biotherapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iovance Biotherapeutics Accounts Payable & Accrued Expense Chart

Iovance Biotherapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

48.59

84.14

78.90

102.53

109.45

Iovance Biotherapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															72.14	82.20	106.51	109.45	113.19

Iovance Biotherapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Iovance Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Iovance Biotherapeutics Inc (LTS:0JDK) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

IOVA:USA 2LB:Germany

Address

825 Industrial Road, Suite 100, San Carlos, CA, USA, 94070

Website

https://www.iovance.com

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Iovance Biotherapeutics Headlines

No Headlines